ROSULAD

This brand name is authorized in Nigeria.

Active ingredients

The drug ROSULAD contains one active pharmaceutical ingredient (API):

1	Rosuvastatin UNII 83MVU38M7Q - ROSUVASTATIN CALCIUM
	Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase. Rosuvastatin increases the number of hepatic LDL receptors on the cell-surface, enhancing uptake and catabolism of LDL and it inhibits the hepatic synthesis of VLDL, thereby reducing the total number of VLDL and LDL particles.
	Read more about Rosuvastatin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9055	Tablet	ROSULAD - 10 TABLETS TAB 10 mg 3x10	16 RNW-PP-333408 ROSULAD - 10 TABLETS ROSUVASTATIN CALCIUM ROSUVASTATIN CALCIUM EQ. TO ROSUVASTATIN 10MG B4-9055 Drugs Imported Products 3X10 Prescription Only Medicine (POM) 6/23/2023 LADFIELD GLOBAL RESOURCES LIMITED, 335 IGBEDE ROAD, AJANGBADI, OJO LAGOS. 8023078302 royelad@yahoo.com GLOBELA PHARMA PVT. LTD., PLOT 357, GIDC, SACHIN, SURAT, GUJARAT, INDIA, India	31/10/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AA07	Rosuvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9055